DrugMonitor™ Anti-Dusigitumab Antibody (VS-1224-YC382) (CAT#: VS-1224-YC382)
Dusigitumab is a human monoclonal antibody targeting IGF2, investigated in trials for cancer, advanced solid malignancies, unresectable or metastatic hepatocellular carcinoma (HCC), and hormone-sensitive, HER-2 negative metastatic breast cancer. The DrugMonitor™ Anti-Dusigitumab Antibody (VS-1224-YC382) is an anti-drug antibody (ADA) against Dusigitumab. This drug-based antibody is raised in mice immunized with the Dusigitumab. The anti-Dusigitumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Dusigitumab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Dusigitumab
- Target
- Dusigitumab
- Immunogen
- Dusigitumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Dusigitumab
- Related Disease
- cancer, advanced solid malignancies, unresectable or metastatic hepatocellular carcinoma (HCC), and hormone-sensitive, HER-2 negative metastatic breast cancer
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "dusigitumab"
Anti-IGF2 Recombinant Antibody (Dusigitumab)Recombinant human monoclonal antibody expressed in CHO binding to human IGF2. Dusigitumab is a human monoclonal antibody designed for the treatment of cancer.
Afuco™ Anti-IGF2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-740)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human IGF2. It is a human monoclonal antibody designed for the treatment of cancer.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1224-YC382. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IHC, ELISA, FC, WB, ADCC, FuncS
Application: ELISA, IHC, FC, IP, IF, Inhib
Application: ELISA, Neut
Application: FC, IA, IF, IP, IHC, FuncS
Application: ELISA, WB
Application: ELISA, FC, WB, Inhib, IHC
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.